Catalyst Wire Dossier Catalyst Wire Dossier

Epclusa

sofosbuvir/velpatasvir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for Epclusa, covering 2016-06-28 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

See pricing